Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation

Transplantation Proceedings

Volumn 42, Issue 9, 2010, Pages 3574-3577

  Lochmanova, A ^a   Lochman, I ^a   Tomaskova, H ^a   Marsalkova, P ^a   Raszka, J ^a   Mrazek, J ^a   Dedochova, J ^a   Martinek, A ^a   Brozmanova, H ^a  

^a Zdravotniho ustavu se sidlem v Ostrave   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

ADULT; AGED; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CZECH REPUBLIC; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VIRAL LOAD; VIRUS LATENCY; YOUNG ADULT;

EID: 78649471511     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.07.101     Document Type: Article

References (17)

1. A. Harari, S.C. Zimmerli, and G. Pantaleo Cytomegalovirus (CMV)-specific cellular immune responses Hum Immunol 65 2004 500
2. M.D. Pescovitz Review of the CMV in renal transplantation Saudi J Kidney Dis Transpl 18 2007 505
3. A. Egli, S. Binggeli, and S. Bodaghi Cytomegalovirus and polyomavirus BK posttransplant Nephrol Dial Transplant 22 suppl 8 2007 viii72
4. B. Naumnik Comparison of serology assays and polymerase chain reaction for themonitoring of active cytomegalovirus infection in renal transplant recipients Transplant Proc 39 2007 2748
5. R.J. Kowalski Assessing relative risks of infection and rejection: a meta-analysis using animmune function assay Transplantation 82 2006 663
6. S.F. Stone, P. Price, and M.A. French Cytomegalovirus (CMV)specific CD8+ T cells in individualswith HIV infection: correlation with protection from CMV disease J Antimicrob Chemother 57 2006 585
7. D. Hughes Donor and recipient CMV serostatus and antigenemia after renal transplantation:an analysis of 486 patients J Clin Virol 41 2008 92
8. K.P. Singh Human cytomegalovirus (CMV)specific CD8+ T cell responses are reduced inHIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery Clin Immunol 124 2007 200
9. G.P. Westall, N.A. Mifsud, and T. Kotsimbos Linking CMV serostatus to episodes of CMV reactivationfollowing lung transplantation by measuring CMV-specific CD8+ T-cell immunity Am J Transplant 8 2008 1749
10. B.C. Weikert, and E.A. Blumberg Viral infection after renal transplantation: surveillance andmanagement Clin J Am Soc Nephrol 3 suppl 2 2008 S76
11. T. Bunde Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells J Exp Med 201 2005 1031
12. D. Kumar Cell-mediated immunity to predict cytomegalovirus disease in high-risk solidorgan transplant recipients Am J Transplant 9 2009 1214
13. P. Moss, and N. Khan CD8(+) T-cell immunity to cytomegalovirus Hum Immunol 65 2004 456
14. S. Walker Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responsesusing Quantiferon-CMV Transpl Infect Dis 9 2007 165
15. J.B. Lim Adoptive immunotherapy for cytomegalovirus (CMV) disease inimmunocompromised patients Yonsei Med J 45 suppl 2004 18
16. A.P. Huissoon Loss of cytomegalovirus-specific immunological memory in a patient withthymoma Clin Exp Immunol 129 2002 297
17. M. Hummel, and M.M. Abecassis A model for reactivation of CMV from latency J Clin Virol 25 suppl 2 2002 S123